Pharma giant Gilead’s price for coronavirus drug draws criticism

The US maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $US2340 for a typical treatment course.

Leave a Reply

Your email address will not be published. Required fields are marked *